Overview:
Global Beta-thalassemia (B-thal) Market, By Disease Indication (Beta-Thalassemia Intermedia, Beta Thalassemia Major, and Beta Thalassemia Minor), by Treatment (Erythroid Maturation Agents, Iron Chelating Drugs, Stem Cell Therapy, and Others), and by Region (North America, Africa, Asia Pacific, Middle East, Latin America, and Europe) and is approximated to have a market valuation of US$ 411.8 million in 2021 and is anticipated to manifest a CAGR of 7.8% over the forecast period of 2022-2028, as mentioned in a new report published by Coherent Market Insights.
Download Free Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @
https://www.coherentmarketinsights.com/insight/request-sample/4793
Market Drivers:
The rising affected populace suffering from beta-thalassemia worldwide had anticipated forcing marketplace increase over the predicted time.
For instance, based on the report issued in November 2018 by a multinational biopharmaceutical firm, Bristol-Myers Squibb Company explained that approximately 1.5% of the world population are couriers of β-thalassemia. Notwithstanding that β-thalassemia is very uncommon inside the American regional market, there are an anticipated 1.25 million partakers, making up 0.4% of the populace. Furthermore, in line with the same reserve, thalassemia impacts about 2,000 patients in the American regional market, with 1,000 sufferers having β-thalassemia fundamental.
For instance, based on the report published in June 2019 by the Journal of European Hematology Association described that the yearly incidence of symptomatic people suffering from β-thalassemia had anticipated at between one in 100,000 globally and one in 10,000 in Europe.
Impact of Coronavirus (Covid-19) Pandemic:
In the course of this COVID-19 pandemic, pharmaceutical enterprises, clinical device establishments, and also biotechnology corporations are encountering tribulations that are appearing from the interruption in supply channels and the need to convert service operations. As the researchers monitor there may be no dating between beta-thalassemia in addition to coronavirus, as a result, the beta-thalassemia market is being stricken by the pandemic. If the COVID-19 pandemic proceeds for a medium/lengthy period, it may affect the product delivery and also active ingredients around the sector in conjunction with the import in addition to the medication exportation. There has been a disruption in the remedy demand. As coronavirus has become the fundamental force at the beta-thalassemia market and all have a look at institutes, biotech in addition to pharmaceutical agencies are established in collaboration activity for controlling COVID-19, who’s formerly engaged in research and development of therapeutics for the therapy of beta-thalassemia.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/4793
Market Restraint:
The inflexible expenses and restitution guidelines, along with the elevated price of medications utilized in the therapy of beta-thalassemia, are the characteristics that had anticipated to inhibit the development of the global beta-thalassemia market in the predicted period.
Key Players:
Major organizations working in the global beta-thalassemia (B-thal) market contain Agios Pharmaceuticals, Bluebird Bio, Celgene Corp., CRISPR Therapeutics, DisperSol Technologies, Editas Medicine, Global Blood Therapeutics, Incyte Corporation, Ionis Pharmaceuticals, Kiadis Pharma, Orchard Therapeutics, Protagonist Therapeutics, Sangamo Therapeutics, Syros Pharmaceuticals, and Vifor Pharma.
Detailed Segmentation:
Global Beta-thalassemia (B-thal) Market, By Treatment:
-
- Iron Chelating Drugs
- Erythroid Maturation Agents
- Stem Cell Therapy
- Others
Global Polycythemia Vera Therapeutics Market, By Disease Indication:
-
- Beta Thalassemia Minor
- Beta Thalassemia Intermedia
- Beta Thalassemia Major
Reasons to Buy this Beta-thalassemia (B-thal) Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Beta-thalassemia (B-thal) market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Beta-thalassemia (B-thal) market
➡Leading company profiles reveal details of key Beta-thalassemia (B-thal) market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Beta-thalassemia (B-thal) market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Buy This Complete Business Report @
https://www.coherentmarketinsights.com/insight/buy-now/4793
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Treatment
- Market Snippet, By Disease Indication
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Reimbursement Scenario
- Mergers & Acquisitions
- Market Dynamics
- Global Beta-thalassemia (B-thal) Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- Global Beta-thalassemia (B-thal) Market, By Treatment, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Iron Chelating Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Erythroid Maturation Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Beta-thalassemia (B-thal) Market, By Disease Indication, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Beta Thalassemia Minor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Beta Thalassemia Intermedia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Beta Thalassemia Major
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Beta-thalassemia (B-thal) Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018–2028
- North America
- Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Region/Country, 2017 – 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Celgene Corp.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BlueBird Bio
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Protagonist Therapeutics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Agios Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Ionis Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vifor Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Orchard Therapeutics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sangamo Therapeutics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- CRISPR Therapeutics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- DisperSol Technologies
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Kiadis Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Incyte Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Editas Medicine
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Global Blood Therapeutics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Syros Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Celgene Corp.
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837